Stanniocalcin 2 (STC2) expression promotes post-radiation survival, migration and invasion of nasopharyngeal carcinoma cells
Open Access
- 1 July 2019
- journal article
- research article
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 11, 6411-6424
Abstract
Background: Stanniocalcin 2 (STC2) expression is upregulated under multiple stress conditions including hypoxia, nutrient starvation and radiation. Overexpression of STC2 correlates with tumor progression and poor prognosis. Purpose: We previously demonstrated that overexpression of STC2 in nasopharyngeal carcinomas (NPC) positively correlates with radiation resistance and tumor metastasis, two major clinical obstacles to the improvement of NPC management. However, it remains elusive whether STC2 expression is a critical contributing factor for post-radiation survival and metastasis of NPC cells. Materials and methods: Using the radiation resistant CNE2 cell line as a model, we examined the importance of STC2 expression for post-radiation survival, migration and invasion. Here, we report the establishment of STC2 knockout lines (CNE2-STC2-KO) using the CRISPR/Cas9-based genome editing technique. Results: Compared with the parental line, STC2-KO cells showed similar proliferation and morphology in normal culture conditions, and loss of STC2 did not compromise the cell tumorigenicity in nude mice model. However, STC2-KO lines demonstrated increased sensitivity to X-radiation under either normoxic or hypoxic conditions. Particularly, upon X-radiation, parental CNE2 cells only slightly whereas STC2-KO cells remarkably decreased the migration and invasion ability. Cell cycle analysis revealed that loss of STC2 accumulated cells in G1 and G2/M phases but decreased S-population. Conclusion: These data indicate that the expression of STC2, which can be stimulated by metabolic or therapeutic stresses, is one important factor to promote survival and metastasis of post-radiation NPC cells. Therefore, targeting STC2 or relative downstream pathways may provide novel strategies to overcome radiation resistance and metastasis of NPC.Keywords
This publication has 38 references indexed in Scilit:
- Clinical significance of stanniocalcin-1 detected in peripheral blood and bone marrow of esophageal squamous cell carcinoma patientsJournal of Experimental & Clinical Cancer Research, 2012
- Stanniocalcin 2 Is a Negative Modulator of Store-Operated Calcium EntryMolecular and Cellular Biology, 2011
- Stanniocalcin-2 promotes epithelial–mesenchymal transition and invasiveness in hypoxic human ovarian cancer cellsExperimental Cell Research, 2010
- Clinical Significance of Stanniocalcin 2 as a Prognostic Marker in Gastric CancerAnnals of Surgical Oncology, 2010
- Stanniocalcin 2 promotes invasion and is associated with metastatic stages in neuroblastomaInternational Journal of Cancer, 2009
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006
- DNA damage response as a candidate anti-cancer barrier in early human tumorigenesisNature, 2005
- DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociationNature, 2003
- Molecular Cloning of a Second Human Stanniocalcin Homologue (STC2)Biochemical and Biophysical Research Communications, 1998
- Cyclins, Cyclin-Dependent Kinases and Cdk Inhibitors: Implications in Cell Cycle Control and CancerCritical Reviews™ in Eukaryotic Gene Expression, 1995